SI-BONE, Inc.
NASDAQ:SIBNMedical - Devices
+$0.53 today
- Market cap
- $1.06B
- Beta
- 0.70
- P/E (TTM)
- -41.4
- EPS (TTM)
- -$0.38
Volume 1.12M
Average 0.68M
SIBN Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
SI-BONE, Inc.NASDAQ: SIBN
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns negative
Q1 FY2026 investing cash flow was -$6.23M, compared with $10.63M a year earlier. Trailing-twelve-month investing cash flow was -$12.7M.
Context
- Investing cash flow amounted to 2.1% of revenue in FY2025, down 5.5 pp from a year earlier.
- Investing cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly investing cash flow holds near -$6.23M or moves back toward the trailing-twelve-month quarterly average of -$3.18M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 4.16M USD
- Year-over-year change
- -67.0%
- 4-year CAGR
- -46.7%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.16M | -67.0% |
| FY2024 | 2024-12-31 | 12.62M | +121.1% |
| FY2023 | 2023-12-31 | (59.8M) | -2024.3% |
| FY2022 | 2022-12-31 | (2.82M) | -105.5% |
| FY2021 | 2021-12-31 | 51.58M | — |
Investing Cash Flow vs competitors
How SIBN compares with its peers on the latest reported figures
- SIBN's LTM Mar 2026 investing cash flow of $12.7M is the smallest of the 6 companies compared; the peer median is $406M.
- Its year-over-year change of -175.1% is the lowest of 6, against a peer median of -13.3%.
- Investing cash flow amounts to 6.2% of revenue for SIBN, versus a peer median of 6.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.45B | -78.4% | +18.5% | 5.6% | |
| LTM Jun 2026 | $499.01M | +74.0% | +47.6% | 15.9% | |
| FY2025 | $406M | -28.6% | -4.9% | 6.6% | |
| LTM Mar 2026 | $61.69M | -13.3% | -2.9% | 7.8% | |
| LTM Mar 2026 | $13.92M | -0.4% | -56.2% | 1.0% | |
| LTM Mar 2026 | $12.7M | -175.1% | — | 6.2% | |
| Peer median (excluding SIBN) | $406M | -13.3% | -2.9% | 6.6% | |
Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (56.57M) | (61.26M) | (43.34M) | (30.91M) | (18.9M) |
| Depreciation & Amortization | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M |
| Deferred Income Tax | 3.56M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 16.87M | 23.06M | 24.06M | 25.87M | 25.52M |
| Change in Working Capital | (5.76M) | (7.64M) | (4.83M) | (10.12M) | (14.33M) |
| Accounts Receivables | (569K) | (6.48M) | (2.12M) | (5.84M) | (3.03M) |
| Inventory | (5.78M) | (5.71M) | (4.72M) | (8.05M) | (8.68M) |
| Accounts Payables | (532K) | 2.53M | (1.12M) | 1.86M | (1.76M) |
| Other Working Capital | 1.13M | 2.02M | 3.13M | 1.91M | (851K) |
| Other Non-Cash Items | 288K | 730K | (29K) | (1.64M) | 4.31M |
| Operating Cash Flow | (39.53M) | (41.66M) | (18.71M) | (12.43M) | (675K) |
| Capital Expenditures | (6.39M) | (9.51M) | (7.8M) | (10.5M) | (8.41M) |
| Acquisitions (Net) | (57.97M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (102.02M) | (119.51M) | (189.5M) | (205.38M) | (192.53M) |
| Sales of Investments | 159.99M | 126.2M | 137.5M | 228.5M | 205.1M |
| Other Investing Activities | 57.97M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 51.58M | (2.82M) | (59.8M) | 12.62M | 4.16M |
| Debt Repayment | (6.62M) | 0 | 725K | (46K) | 0 |
| Common Stock Issued | 4.91M | 2.2M | 83.67M | 2.72M | 3.38M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 6.54M | (720K) | 0 |
| Financing Cash Flow | (1.71M) | 2.2M | 90.93M | 1.96M | 3.38M |
| Effect of Forex Changes | (498K) | (429K) | 132K | (479K) | 431K |
| Net Change in Cash | 9.84M | (42.7M) | 12.55M | 1.68M | 7.29M |
| Free Cash Flow | (45.92M) | (51.16M) | (26.51M) | (22.92M) | (9.09M) |
SI-BONE, Inc.
NASDAQ:SIBN
Intrinsic Alpha fair value
Locked
Current Price
$23.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.